Compression Therapy Industry Overview

The global compression therapy market size was valued at USD 4.07 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.62% from 2024 to 2030. The driving factors of the growth are attributed to rising prevalence of vein disorders such as leg ulcers, Deep Vein Thrombosis (DVT), lymphedema, varicose veins and blood clots. According to a report published by Frontiers Media S.A. in September 2023, the global incidence of five cases in 100,000 individuals is found. The incidence of this condition varies with age and affects 2-3 individuals per 100,000 in the 30-49 age group and about 20 individuals per 100,000 in the 70-79 age group. Owing to such incidences, products such as stockings and bandages are increasingly used to treat the disorders boosting the market growth.

Factors such as geriatric population, inactive lifestyles, and obesity play an important role causing conditions such as chronic venous insufficiency and venous ulcers impacting several people globally. The rising prevalence of venous ulcers paves way for advanced treatment alternatives such as compression therapy as it is highly effective to treat venous ulcers. In addition, compression therapy is an effective treatment for varicose veins compared to other alternatives. For instance, according to the Chicago Vein Institute, nearly 40 million people in U.S. suffer from varicose veins. In addition, according to the data published by NCBI in February 2024, approximately 150,000 new cases are diagnosed with chronic venous insufficiency condition with nearly USD 500 million being spent on the care of these patients.

Gather more insights about the market drivers, restrains and growth of the Compression Therapy Market

Compression therapy works by applying pressure to the limbs, which helps in relieving symptoms, increasing blood flow, and reducing swelling. This ultimately aids in healing and prevents complications. Therefore, rising awareness of the benefits of compression therapy in treating chronic vein condition is expected to boost market growth.

The rise in the number of orthopedic procedures is another factor causing an increased demand for compression therapy as a component of postoperative care and rehabilitation protocols. The major factors causing rise in these procedures are attributed to increased geriatric population, sport-related injuries and advancements in surgical techniques giving rise to orthopedic surgeries, such as joint replacements (knee or hip replacements), fracture repairs, ligament reconstruction and arthroscopic surgeries. For instance, the American College of Rheumatology recorded about 790,000 knee replacement surgeries and 544,000 hip replacement procedures being conducted annually, and the number continues to increase owing to the rise in geriatric population.

After orthopedic surgery, patients often experience swelling, inflammation, and reduced mobility in the operated limbs. Compression therapy can benefit patients with these postoperative symptoms and provide a speedy recovery by improving blood circulation, reducing swelling, and providing relief in the operated area.

Obesity is another risk factor leading to the growing adoption of compression therapy in managing health concerns. Characterized by excessive body fat accumulation, obesity increases the risk of chronic diseases such as CVD, diabetes and hypertension, as well as causing venous insufficiency and associated disorders. For instance, according to the International Journal of Medical Science and Clinical Invention article published in 2023, obesity gives rise to conditions such as venous insufficiency and related complications by more than six-fold. In addition, according to the World Health Organization (WHO), about 2.5 billion adults aged 18 and above were found to be overweight of which 890 million were found living with obesity in 2022.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Key Compression Therapy Company Insights

Cardinal Health; Julius Zorn GmbH; Hartmann AG; Medi GmbH & Co.; SIGVARIS; BSN Medical GmbH; ArjoHuntleigh; 3M Health Care; Spectrum Healthcare; Bio Compression Systems, Inc.; Stryker; Gottfried Medical, are some of the major players in the global market. The market has been witnessing notable trends that are impacting the activities of emerging players in the industry. The key players offer a wide range of compression therapy products such as compression garments, stockings, wraps, and devices to treat various medical conditions including venous disorders, lymphedema, and wound healing. Additionally, new players are emerging, and various startups are entering the industry to offer innovative solutions and disrupt traditional market dynamics. These companies focus on niche segments or develop novel technologies to address unmet needs in wound care management and vascular health.

Furthermore, technological advancements in compression therapy have l;ed to development of innovative products and treatment modalities. Some notable advancements include smart compression technology, 3D printing, gradient compression systems, cold compression therapy, hydrotherapy compression devices, etc. Besides, companies in the global market are increasingly focusing on developing patient-centric solutions prioritizing comfort, convenience, and usability.

Key Compression Therapy Companies:

The following are the leading companies in the compression therapy market. These companies collectively hold the largest market share and dictate industry trends.

  • Essity Aktiebolag (publ).
  • Cardinal Health
  • Julius Zorn GmbH
  • Hartmann AG
  • Medi GmbH & Co.
  • SIGVARIS
  • BSN Medical GmbH
  • ArjoHuntleigh
  • 3M Health Care
  • Spectrum Healthcare
  • Bio Compression Systems, Inc.
  • Stryker
  • Gottfried Medical
  • Tactile Medical

Recent Developments

  • In June 2023, Medi GmbH Co. introduced new medical compression offerings including circular & flat-knit variants, designed to cater to diverse needs and preferences in the healthcare sector.
  • In October 2023, MediWound announced strategic partnership with 3M for clinical trial of EscharEx phase III.
  • In September 2023, Tactile Medical received a patent for a new compression garment system. This system uses adjustable pressure to move fluids within the body towards specialized cells that help manage those fluids.
  • In May 2022, Medline Industries, LP. Launched skin health and compression workshops for Healthline workers.

Order a free sample PDF of the Compression Therapy Market Study, published by Grand View Research.